Key Updates On 3 FTSE Listed Stocks: Red Rock Resources PLC, Nuformix PLC And Huntsworth PLC

  • Dec 24, 2019 GMT
  • Team Kalkine
Key Updates On 3 FTSE Listed Stocks: Red Rock Resources PLC, Nuformix PLC And Huntsworth PLC
Red Rock Resources PLC (LON: RRR)

United Kingdom-based natural resource exploration such as gold & manganese and development group, Red Rock Resources plc principal activities include gold exploration in Ivory Coast and Kenya. In addition, the group holds three assets in the form of wells in the Shoats Creek Field.

RRR-Business performance for FY19 period ended 30th June 2019

(Source: Company’s filings, London Stock Exchange)

The company’s loss for the year was recorded at £1,723,881 in the financial year 2019 as against profit of £78,120 in the financial year 2018. The company had cash balances of £63,828 in the financial year 2019. The short-term borrowings of the company increased to £1,121,392 in the financial year 2019 from £1,008,825 in the financial year 2018.

RRR - Stock price performance

(Source: Thomson Reuters) Daily Chart as on Dec-24-19, before the LSE market close

The market capitalisation of the company while writing as on 24th December 2019 (at 12:15 PM GMT) was approximately £2.89 million.

While writing, Red Rock Resources PLC’s shares were trading at GBX 0.44 per share; which were flat in comparison to the previous day closing price level.

The shares of the Red Rock Resources PLC have struck a high of GBX 0.75 (as on March 08, 2019) and a low of GBX 0.371 (as on December 24, 2019) in the last twelve months. At the current price point, as quoted in the price chart, the company’s shares were trading 44 per cent below the high price point attained in the last twelve months and 13.21 per cent above the low price point attained in the last twelve months.

At the time of writing, the stock's average daily traded volume for 5 days was 900,263.40; 30 days- 766,277.07 and 90 days – 997,477.70. The 5 days daily average traded volume of the shares of the company was up by 17.49 per cent in comparison to 30 days daily average traded volume. The shares of the company were trading below the 30-days and 60-days SMA while writing.

On a YTD (Year-to-Date) time interval, the shares of Red Rock Resources PLC plunged by approximately 29.17 per cent and were up by 10.53 per cent in the last quarter. However, Red Rock Resources PLC’s shares have delivered 26.09 per cent negative return in the last one-year period.

Nuformix PLC (LON: NFX)

United Kingdom-headquartered, Nuformix PLC is a pharmaceutical development company which has invested in cocrystal R&D (Research and Development). With main programmes focussed in oncology supportive care and fibrosis, the group looks forward to unlocking the therapeutic potential of drugs (already approved) by yielding multiple product opportunities along with a portfolio of intellectual property and conducting world-class know-how in cocrystal discovery and development. The group operates a semi-virtual business model to maximise the efficiency of its investments.

NFX - Business performance for H1 FY20

(Source: Company’s filings, London Stock Exchange)

The company’s Total revenue in the period was recorded at £535,000 as compared to £610,000 in the first half of the fiscal year 2019. The company’s Gross profit in the period was recorded at £429,583 as compared to £530,567 in the first half of the fiscal year 2019. The company incurred Loss on ordinary activities during the period amounting to £131,842 in comparison to loss of £642,633 in the first half of the fiscal year 2019. The company’s loss per share stood at 0.03 pence during the period as against a loss of 0.14 pence in the first half of the fiscal year 2019. The company’s net assets were valued at £3,980,126 at the end of the period as compared to £4,616,176 in the first half of the fiscal year 2019. The company was successful in raising cash of £1.25 million excluding issue expenses on 23 December 2019.

NFX-Stock price performance

(Source: Thomson Reuters) Daily Chart as on Dec-24-19, before the LSE market close

The market capitalisation of the company while writing as on 24th December 2019 (at 12:24 PM GMT) was approximately £35.88 million.

While writing, Nuformix PLC’s shares were trading at GBX 7.16 per share; which were 1.92 per cent down in comparison to the previous day closing price level.

The shares of the Nuformix PLC have struck a high of GBX 14.89 (as on June 24, 2019) and a low of GBX 1.90 (as on February 14, 2019) in the last twelve months. At the current price point, as quoted in the price chart, the company’s shares were trading 51.91 per cent below the high price point attained in the last twelve months and 276.84 per cent above the low price point attained in the last twelve months.

At the time of writing, the stock's average daily traded volume for 5 days was 4,777,302.00; 30 days- 5,006,781.97 and 90 days – 4,057,863.64. The 5 days daily average traded volume of the shares of the company was down by 4.58 per cent in comparison to 30 days daily average traded volume. The shares of the company were trading below the 30-days and 60-days SMA while writing.

On a YTD (Year-to-Date) time interval, the shares of Nuformix PLC surged by approximately 247.62 per cent and were up by 13.18 per cent in the last quarter. However, Nuformix PLC’s shares have delivered 13.10 per cent negative return in the last one-month period.

Huntsworth PLC (LON: HNT)

Huntsworth PLC is a London-headquartered international communications and healthcare company which seeks to generate value through a network of specialist agencies. The company is primarily focussed on providing medical communications and marketing services to its clients from the healthcare sector, which includes mid and large biotech and pharmaceutical companies. The company also offers a variety of services related to advisory and communications to smaller companies. The operations of the group are differentiated in four operating segments, namely Communications, Immersive, Medical and Marketing.

HNT-Trading update for 11-month period ended 30th November 2019

The trading performance of the company was satisfactory and in line with the management’s expectations. The marketing segment witnessed growth. The group’s acquisitions were well integrated, and they performed in accordance with the company’s expectations. The group’s cash generation remained strong which puts the group in a strong financial position and expected leverage is 1.6x at the year-end.

HNT-Stock price performance

(Source: Thomson Reuters) Daily Chart as on Dec-24-19, before the LSE market close

The market capitalisation of the company while writing as on 24th December 2019 (at 12:29 PM GMT) was approximately £305.11 million.

While writing, Huntsworth PLC’s shares were trading at GBX 81.20 per share; which were 0.98 per cent down in comparison to the previous day closing price level.

The shares of the Huntsworth PLC have struck a high of GBX 112.00 (as on January 30, 2019) and a low of GBX 58.24 (as on December 18, 2019) in the last twelve months. At the current price point, as quoted in the price chart, the company’s shares were trading 27.50 per cent below the high price point attained in the last twelve months and 39.42 per cent above the low price point attained in the last twelve months.

At the time of writing, the stock's average daily traded volume for 5 days was 2,071,646.40; 30 days- 821,050.40 and 90 days – 517,151.00. The 5 days daily average traded volume of the shares of the company was up by 152.32 per cent in comparison to 30 days daily average traded volume. The shares of the company were trading below the 30-days and 60-days SMA while writing.

On a YTD (Year-to-Date) time interval, the shares of Huntsworth PLC plunged by approximately 24.07 per cent and were down by 11.06 per cent in the last quarter. However, Huntsworth PLC’s shares have delivered 5.20 per cent negative return in the last one-month period.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK